← FDA Drug Approvals (Drugs@FDA)
DALFAMPRIDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2019-05-21
Drug application
- FDA Application #
ANDA208292- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DALFAMPRIDINE
- Generic name
- DALFAMPRIDINE
- Active ingredients
- DALFAMPRIDINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- SUN PHARM
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- First approval
- 2019-05-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown